This month we asked patient organisations to share their achievements from 2020 and their goals for 2021 as well as their latest news.
Asociación de Apoyo e Información a Familiares y Pacientes con Neumonía (NEUMOAI) accomplished their goals they had set for 2020.
NEUMOAI is planning a new impact campaign for World Pneumonia Day 2021 with the aim of giving visibility to pneumonia.
Due to the COVID-19 pandemic, in 2020 Fundació Respiralia has not been able to carry out two of their famous annual projects:
However, they managed to carry out other solidarity events which were very successful, such as the first Walking Tour around Mallorca for Cystic Fibrosis, Serra4Life, and donations from the book “Somiant”.
In 2021, the Foundation wishes for good health. Even if the coronavirus goes away, cystic fibrosis (CF) will still exist, so they will continue working to improve the quality of life of people with CF, offering care from their professionals, and pushing the government to authorise and finance Trikafta/Kaftrio, a drug to treat CF, in Spain. https://cutt.ly/ijaXSxV
Action for Pulmonary Fibrosis (APF) is needed more than ever as the United Kingdom is in a third national lockdown and people with pulmonary fibrosis (PF) continue to shield. The APF team is committed to supporting anyone affected by PF through these uncertain times. The organisation has adapted their services quickly during the pandemic. During 2020 they worked hard to connect support groups digitally so they can access peer support and feel connected. This work continues to help reduce isolation and keep patients and families informed. Unsurprisingly, calls and emails to their support line increased significantly last year and they plan to continue to grow this service to meet the demand. Funding vital research is a key area of work for APF. They will be spearheading their new research appeal this year alongside their research strategy. Finding a cure for PF drives their patients, their families, and fundraisers.
Respiriamo Insieme has recently launched a new information awareness campaign: ‘Severe Asthma. Knowing the Difference Makes the Difference’. This campaign aims to raise awareness on a condition that is different from asthma, more severe, and that affects 5-10% of all people with asthma.
The outcomes they want to achieve are to:
So far, this campaign has been well received among patients, who have sent more than 500 emails requesting help and support to the association’s email address. More than 1,600 people have joined Respiriamo Insieme’s Facebook page in a month. The video campaign has reached 2 million viewers, and the social media campaign has reached 6 million people, creating 8500 interactions.
Respiriamo Insieme recently made a video, with English subtitles, on the topic. Watch the video.
During 2020, Fundación Lovexair has been at the core of the fight against the pandemic providing meaningful resources to people in e-health and providing workshops with more than 480 participants from 13 Spanish-speaking countries, recently extending their outreach to Portugal and Brazil. All to help respiratory patients tackle their concerns and care management issues for COVID-19 where physical and emotional needs must now be met in alternative ways (#RespiraLATAM & #CercaDeTi).
Lovexair is also engaged in several international projects with a growing network of IT and multi-partner stakeholders, such as their asthma virtual assistant #Altys (http://happyair.org/altys/) which includes clinical and scientific expertise, startup devices and industry leadership, recently re-launched for their international European project #Improvid (http://happyair.org/improvid/).
2021 will be a special year for Alpha1 Deutschland e.V. The organisation was founded exactly 20 years ago and has grown steadily since then. It has grown not only in members but also in knowledge and influence. It currently has over 850 members in Germany (a lot for a rare disease organisation) and has already been able to help many people with Alpha1 deficiency. They want to celebrate this in the autumn and hope that life can go back to normal again following the COVID-19 pandemic.
Alfa1 Sverige has not been able to carry out many of the activities they had hoped to due to the COVID-19 pandemic. However, some of their achievements included:
If the situation with the pandemic permits, in 2021 Alfa1 Sweden plans to hold a conference with a variety of speakers, and also hold an Alpha Kids and Parents meeting which will include going to an amusement park.
The European Pulmonary Hypertension Association (PHA Europe) was involved with the new European Respiratory Society (ERS) statement on chronic thromboembolic pulmonary hypertension (CTEPH), which has now been published online in the European Respiratory Journal (ERJ) as an early view. The paper aims to summarise the most recent developments in the field of CTEPH. PHA Europe was invited to represent the patient perspective and contribute to the paper as a co-author. Read the statement.
The Slovenian PH association, Društvo za pljučno hipertenzijo Slovenije, in cooperation with PHA Europe ran an informative COVID-19 awareness campaign in November. Many PH patients and carers were interviewed and had the opportunity to share their thoughts and feelings about the pandemic. The common message was the importance of following the security measures, taking care of each other and wearing masks to help save lives. Read quotes and watch videos from the campaign.
You can follow the social media platforms and use the following hashtags in your search field: #COVIDawareness #youngpatient #Raredisease #phPatient
PHURDA Ukraine held activities to collect and present gifts to children with pulmonary hypertension (PH), children of PH patients, and children whose parents died from PH, on St. Nicholas Day (19 December). Traditionally in Ukraine on this day, children get presents from St. Nicholas.
PHA Europe’s project “O2Kids” held a fundraising campaign to buy electric scooters with portable oxygen concentrators for children. As part of the project, Khrystynka Makarchuk, a child with PH, and the face of “O2Kids” in Ukraine, received an electric scooter. Also for St. Nicholas Day, as part of this project and with the support of Sister Dalila and “The First Western” TV channel, PHURDA Ukraine presented electric scooters to two more children with PH. This moment was full of emotions and happiness for the children.
PHURDA’s biggest achievements in 2020:
PHURDA’s plans for this year:
Pulmoner Hipertansiyon ve Skleroderma Hasta Derneği (PAHSSc) achieved a lot towards the end of last year. They were involved in several activities including:
For more PAHSSc news, visit www.pahssc.org.tr/faaliyet-raporu/16/faaliyet-raporu-2020
In 2020, the Global Allergy & Airways Patient Platform (GAAPP) in collaboration with AstraZeneca launched the COPD Patient Charter, a document outlining six key principles of quality care that patients deserve to receive.
Watch our webinar on COPD patients’ rights with panelists Dr. John Hurst/UK, Dr. Mohit Bhutani/CA and Tonya Winders/USA.
GAAPP President Tonya Winders also co-authored the publication: A worldwide charter for all children with asthma, a roadmap to better education and training with the goal of reducing the global health burden of childhood asthma. Read and download the publication.
Last year the Helping Hands Foundation carried out activities for various awareness days, including World Disability Day and World Children Day to provide information and support. The Foundation was awarded a certificate from the Governor of Punjab for their efforts to encourage the community to follow government guidelines to help stop the spread of COVID-19.
The Helping Hands Foundation is planning activities for even more awareness days in 2021, including World Environment Day, World Lung Day and World Pneumonia Day, where they will carry out various activities to raise public awareness of these topics.
Learn about the factors that can cause lung disease and the ways to reduce your contact with them.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.